Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2012.
On the consolidated basis, the company has reported 9.13% rise in its net profit at Rs 48.27 crore for the quarter as compared to Rs 44.23 crore for the same quarter in the previous year. However, total income of the company has decreased by 3.36% at Rs 369.28 crore for quarter under review as compared to Rs 382.12 crore for the quarter ended December 31, 2011.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.
